Nathan Joh
About Nathan Joh
Nathan Joh is an Associate Director at Generate Biomedicines, Inc., where he leads initiatives to enhance high-throughput processes through automation. He has extensive experience in drug discovery and development, having previously worked at Amgen and Bayer HealthCare.
Work at Generate Biomedicines
Nathan Joh serves as Associate Director at Generate Biomedicines, Inc., a position he has held since 2022. In this role, he leads initiatives aimed at enhancing high-throughput processes through automation. His focus is on improving data collection, processing, and utilization. He directs the acquisition of high-throughput analytical data to support machine learning-driven protein design, which is essential for drug discovery. Additionally, he develops teams that facilitate lead discovery and drug candidate nomination by creating comprehensive biophysical and analytical data packages.
Previous Experience at Amgen
Before joining Generate Biomedicines, Nathan Joh worked at Amgen for a total of five years. He began as a Scientist from January 2016 to October 2017, then advanced to Scientist - Process Development from October 2017 to May 2019. Following this, he served as Senior Scientist - Process Development from 2019 until 2022. His tenure at Amgen was primarily based in Thousand Oaks, CA, where he contributed to various projects related to drug development.
Experience at Bayer HealthCare
Nathan Joh also worked at Bayer HealthCare as a Development Scientist from 2014 to 2016. His role involved contributing to the development of healthcare solutions while based in Berkeley, CA. This position added to his extensive background in scientific research and development within the biopharmaceutical sector.
Educational Background
Nathan Joh holds a PhD in Biochemistry and Molecular Biology from UCLA, where he studied from 2003 to 2009. He also earned a Bachelor of Science in Chemistry, graduating cum laude with a minor in microbiology from California State Polytechnic University-Pomona. His educational background provides a strong foundation for his work in drug discovery and development.